DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aptech Limited — Action(s) taken or orders passed

NSE 2 hrs ago·8 Sept 2026, 12:41 pm

Aptech

Aptech Limited has informed stock exchanges about regulatory actions taken against it. The company has filed an intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015. This disclosure is a standard requirement for listed entities to report significant corporate events or regulatory developments to the market.

For investors, this news signals that the company is adhering to disclosure norms by keeping the market informed. While the specific nature of the action is not detailed in the headline, it is a routine administrative update. Investors should monitor the company's subsequent filings to understand the context and impact of these regulatory actions on its operations.